◆ 会议时间:2020年1月9-10日 ◆ 会议地点:埃及 开罗/Cairo
◆ 会议简介:
2020年第12届乳腺和妇科免疫学国际癌症会议(BGICC)将于2020年1月9-10日在埃及开罗举行。该会议是非洲和中东地区最大的乳腺癌和妇科癌症专题会议,届时将吸引世界各地的一流的肿瘤学家参与,并与全球知名的癌症中心和相关组织进行合作。BGICC将为与会者提供一个交流癌症治疗经验的平台,并概述与乳腺癌,妇科癌症和免疫肿瘤学相关的问题,讨论最新的国际趋势和治疗举措的前景, 会议由BGICS组织。
乳腺-妇科国际肿瘤学会(BGICS)是一个非营利、非政治性的国际多学科组织,由医学肿瘤学家、肿瘤外科学家、妇科医师、放射治疗师、放射科医师和病理学家等专业人士组成。BGICS致力于促进乳腺妇科肿瘤科学的发展,改善全球癌症患者及其家属的护理,目标是减轻全人类癌症患者的痛苦。
Dear Colleagues Welcome to the BGICC 2020 the 12th breast- Gynecological & Immunooncology International Cancer Conference, the largest and most prestigious cancer conference in Africa and the Middle East.
I invite you all to attend the rich content lectures and participate in the workshop and courses, the conference will be held on 9th and 10th January 2020 in Cairo, Egypt. We are gathering all the efforts to build a very strong Multidisciplinary Clinical and Translational Research for the Middle East through our Society BGICS to build a strong base for Egypt, Middle East and Africa in attempt to educate young doctors and medical staff and setting an up to date guidelines. In the 12th BGICC,9th-10th January,2020. We are aiming to set a new bar and reach to the future with our continuous effort as we strongly believe that “Cancer is a disease not a Death Sentence”, through holding Multidisciplinary sessions, workshops as well as some consensus sessions focusing the light on the main points of Debate and there is no doubt that your participation will definitely help us to fulfill this aim. The 11th BGICC was a great success with more than 3000 attendees from Egypt, Middle East and all over the world and with a very successful consensus sessions and acted as “a vibrant and growing Center for the Middle East and a bridge for Oncologists, Radiologists, Pathologists and Surgical Oncologists and all the professionals that participated in Our Multidisciplinary Approach to Cross over to the future in our attempt to find a cure in collaborations with very high caliber societies as (Sitc , ESO, UICC, ASCO, ESTRO, ESSO, APCA, ROAM, BSI, MASRI, ESGO, ESOI, SIOG, BCNET).
◆ 参会对象: 政府代表、医院管理者、科室主任、副主任、医生及从相关领域研究的专家、科研人员、医药企业等。
|